Interpace biosciences, inc. (IDXG)
Income statement / Quarterly
Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15Dec'14Sep'14Jun'14Mar'14Dec'13Sep'13Jun'13Mar'13Dec'12Sep'12Jun'12Mar'12Dec'11Sep'11Jun'11Mar'11Sep'10Jun'10
Revenue, net

4,074

7,725

6,270

6,010

5,833

5,753

5,501

4,809

-

4,202

3,855

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Cost of revenue (excluding amortization of $813 and $813, respectively)

-

-

-

2,622

-

-

-

2,580

-

2,069

1,879

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Revenue, net

-

-

-

-

-

-

-

-

-

-

-

3,470

3,122

3,316

3,612

3,035

2,556

2,506

2,253

2,117

-

-

-

-

32,106

34,260

37,245

42,923

35,632

31,781

27,809

31,677

38,283

36,069

38,637

44,302

35,972

32,849

Cost of revenue (excluding amortization of $3,652 and $3,252, respectively)

-

4,835

3,031

-

-

2,763

2,247

-

-

-

-

1,771

1,774

1,846

1,842

1,179

1,686

1,799

1,851

1,574

-75,669

24,410

25,815

26,712

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Revenues

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

28,264

31,008

31,832

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Cost of services

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

28,619

29,564

30,396

34,450

28,647

25,842

21,239

24,311

29,582

28,394

30,705

36,139

27,489

25,074

Gross profit

-1,326

2,890

3,239

3,388

3,226

2,990

3,254

2,229

2,731

2,133

1,976

1,699

1,348

1,470

1,770

1,856

870

707

402

543

-13,961

3,854

5,193

5,120

3,487

4,696

6,849

8,473

6,985

5,939

6,570

7,366

8,701

7,675

7,932

8,163

8,483

7,775

Operating expenses:
Sales and marketing

2,989

2,757

2,959

2,411

2,287

2,048

2,095

1,991

2,060

1,816

1,555

1,136

1,311

1,282

1,322

1,547

1,971

2,876

3,285

2,226

604

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Research and development

778

857

647

528

595

510

518

501

259

483

413

306

308

659

357

323

646

1,000

414

232

255

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

General and administrative

4,354

4,492

2,788

2,912

2,517

2,084

1,726

2,172

2,722

2,116

2,793

1,522

2,815

2,858

2,015

2,816

7,655

2,498

3,430

3,339

-4,405

6,930

6,255

5,534

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Acquisition related expense

-

838

1,295

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Acquisition related amortization expense

1,031

995

813

813

813

813

813

813

-

813

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Compensation expense

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

1,959

4,231

4,914

4,155

3,688

4,075

4,069

4,582

4,544

4,171

5,702

5,277

4,518

4,528

Other selling, general and administrative expenses

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

2,319

2,517

2,782

2,065

3,013

2,620

2,817

3,005

3,705

3,309

3,301

4,275

3,545

3,300

Acquisition related amortization expense

-

-

-

-

-

-

-

-

-

-

813

813

860

970

970

970

970

986

986

870

674

126

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Asset impairment

-

-

-

-

-

-

-

-

-

-

-

-

-

3,363

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Change in fair value of contingent consideration

-

-

-

-

-

-

-

-

174

0

0

-5,776

-10,686

-1,174

0

0

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Facilities realignment

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

583

Total operating expenses

9,509

9,939

8,502

6,664

7,734

5,455

5,152

5,477

6,029

5,228

5,574

-1,999

-5,392

7,958

4,664

5,656

20,788

7,360

8,115

6,667

-813

7,056

6,255

5,534

4,278

6,748

7,696

6,220

30,924

6,695

6,886

7,587

11,138

7,480

9,003

9,552

8,063

8,411

Operating loss

-10,835

-7,049

-5,263

-3,276

-4,508

-2,465

-1,898

-3,248

-3,298

-3,095

-3,598

3,698

6,740

-6,488

-2,894

-3,800

-19,918

-6,653

-7,713

-6,124

-13,148

-3,202

-1,062

-414

-791

-2,052

-847

2,253

-23,939

-756

-316

-221

-2,437

195

-1,071

-1,389

420

-636

Accretion expense

109

111

91

129

-

248

-

-

-

40

-

-

-

-

-

-

-

-

-

-

-

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Interest expense

-

-

-

-

-

-

-

-

-

-

216

254

544

539

858

203

1,089

884

884

848

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Loss on extinguishment of debt

-

-

-

-

-

-

-

-

0

0

-2,731

-1,547

0

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Other income (expense), net

209

-135

74

48

407

-288

33

111

-1,790

-294

-8

-36

1

4

3

6

174

-112

-69

-86

-18

-20

-13

-17

-29

3

-24

-9

-12

0

-15

-1

125

-48

-26

-65

58

10

Loss from continuing operations before tax

-10,735

-7,295

-5,280

-3,357

-4,184

-3,001

-1,865

-3,137

-5,011

-3,429

-6,553

1,861

6,197

-7,023

-3,749

-3,997

-20,833

-7,649

-8,666

-7,058

-13,768

-3,222

-1,075

-431

-820

-2,049

-871

2,244

-23,951

-756

-331

-222

-2,312

147

-1,097

-1,454

478

-626

(Benefit) provision for income taxes

-47

9

5

5

-3

7

8

6

-55

-42

-301

3

-108

173

-236

9

-12,706

-180

-177

-73

-5,225

64

65

66

-12

64

64

64

-10

74

63

81

-264

183

185

-1,043

71

70

Loss from continuing operations, net of tax

-10,688

-7,304

-5,285

-3,362

-4,181

-3,008

-1,873

-3,143

-4,956

-3,387

-6,252

1,858

6,305

-7,196

-3,513

-4,006

-8,127

-7,469

-8,489

-6,985

-8,543

-3,286

-1,140

-497

-808

-2,113

-935

2,180

-23,941

-830

-394

-303

-2,048

-36

-1,282

-411

407

-696

Net loss

-

-7,362

-5,220

-3,419

-

-3,042

-1,917

-3,193

-5,008

-3,316

-6,306

2,414

6,281

-7,493

-2,334

-4,786

4,385

-4,895

-6,978

-3,868

-7,467

-4,336

-2,658

-1,612

-3,667

-2,141

-883

2,126

-23,797

-1,019

-439

-272

-10,267

-202

-895

-550

-1,674

-890

Net loss attributable to preferred shareholders

-

-7,362

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Less Preferred stock dividends

-

75

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Income (loss) from discontinued operations

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

3,117

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

(Loss) income from discontinued operations, net of tax

-

-

-

-

-

-

-

-

-

71

-54

556

-24

-297

1,179

-780

-

2,574

1,511

-

1,076

-1,050

-1,518

-1,115

-

-28

52

-54

-

-189

-45

31

-

-166

387

-139

-2,081

-194

(Loss) income from discontinued operations, net of tax

-38

-58

65

-57

144

-34

-44

-50

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net loss attributable to common stockholders

-

-7,437

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Unrealized holding loss on available-for-sale securities, net

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

1

-

0

3

2

0

0

1

-1

4

-5

0

2

-1

3

-

-

Net Loss and Comprehensive Loss

-

-

-

-

-

-

-

-

-

-

-

-

-

-7,493

-2,334

-4,786

4,382

-4,895

-6,978

-3,868

-7,468

-4,335

-2,658

-1,612

-3,664

-2,139

-883

2,126

-23,796

-1,020

-435

-277

-10,267

-200

-896

-547

-

-

Basic and diluted (loss) income per share of common stock:
From continuing operations

-

-

-

-

-

-

-

-

-

-0.15

-0.65

0.43

-

-

-1.93

-2.26

-18.58

-0.48

-0.56

-0.46

-0.57

-0.22

-0.08

-0.03

-0.06

-0.14

-0.06

0.15

-

-

-0.03

-0.02

-

-

-

-0.03

0.03

-0.05

From discontinued operations

-

-

-

-

-

-

-

-

-

0.00

-0.01

0.13

-

-

0.65

-0.44

12.27

0.16

0.10

0.21

0.07

-0.07

-0.10

-0.08

-0.18

-0.01

0.00

-0.01

-

-

0.00

0.00

-

-

-

-0.01

-0.15

-0.01

Net loss per basic share of common stock

-

-

-

-

-

-

-

-

-

-0.15

-0.65

0.56

-

-

-1.29

-2.69

-

-

-

-

-

-0.29

-0.18

-0.11

-

-0.15

-0.06

0.14

-

-

-0.03

-0.02

-

-

-

-

-0.12

-0.06

From continuing operations

-

-

-

-

-

-

-

-

-

-0.15

-0.65

0.42

-

-

-1.93

-2.26

-

-

-

-

-

-

-

-

-

-0.14

-0.06

0.14

-

-

-0.03

-0.02

-

-

-

-

0.03

-0.05

From discontinued operations

-

-

-

-

-

-

-

-

-

0.00

-0.01

0.13

-

-

0.65

-0.44

-

-

-

-

-

-

-

-

-

0.00

0.00

0.00

-

-

0.00

0.00

-

-

-

-

-0.14

-0.01

Net loss per diluted share of common stock

-

-

-

-

-

-

-

-

-

-0.15

-0.65

0.55

-

-

-1.29

-2.69

-

-

-

-

-

-

-

-

-

-0.15

-0.06

0.14

-

-

-0.03

-0.02

-

-

-

-

-0.11

-0.06

From continuing operations

-6.80

-0.19

-0.14

-0.10

-4.04

-0.11

-0.07

-0.11

-

-

-

-

-

-3.96

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-0.06

-

-

-

0.00

-0.09

-

-

-

From discontinued operations

-0.02

0.00

0.00

0.00

-

0.00

0.00

0.00

-

-

-

-

-

-0.16

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-0.01

-

-

-

-0.01

0.03

-

-

-

Net loss per basic and diluted share of common stock

-6.82

-0.19

-0.14

-0.10

-4.04

-0.11

-0.07

-0.11

-

-

-

-

-

-4.13

-

-

-6.31

-0.31

-0.46

-0.26

-

-

-

-

-

-

-

-

-

-0.07

-

-

-0.72

-0.01

-0.06

-0.04

-

-

Weighted average number of common shares and common share equivalents outstanding:
Basic

-58,331

38

38,130

35,147

-44,552

28

27,933

27,855

27,085

22,028

9,657

4,294

1,856

1,816

1,816

1,776

-39,703

15,654

15,204

15,037

14,996

14,938

14,910

14,760

14,436

14,740

14,713

14,983

14,626

14,609

14,569

14,536

14,399

14,479

14,413

14,469

14,325

14,289

Diluted

-58,331

38

38,130

35,147

-44,552

28

27,933

27,855

26,995

22,028

9,657

4,384

1,856

1,816

1,816

1,776

-39,703

15,654

15,204

15,037

14,996

14,938

14,910

14,760

14,345

14,740

14,713

15,074

14,626

14,609

14,569

14,536

14,399

14,479

14,413

14,469

14,661

14,289